On January 28, 2020, Charles Lieber, Chair of the Department of Chemistry and Chemical Biology at Harvard University, was arrested and charged in connection with aiding the People’s Republic of China. Dr. Lieber, who served as the Principal Investigator of the Lieber Research Group at Harvard, specializes in nanoscience and has received more than $15,000,000 in funding from the National Institutes of Health (NIH) and Department of Defense (DOD). The charge stems from fraudulent disclosures allegedly made by Dr. Lieber to federal grantors regarding his financial connections to the Chinese government. The criminal prosecution of Dr. Lieber offers a couple of key lessons for federal grantees.
Regulations, Compliance, & Enforcement
Trending Now
GovCon Update: GAO Jurisdiction, DOJ Declination, CUI Rule • Cybersecurity Noncompliance Just Triggered Another False Claims Act Settlement for a Defense Contractor • Update: DFARS Class Deviation Implements Prohibition on Contracting with Lobbyists for Chinese Military Companies • No Place Like Home: The Need for Unique Contractor Addresses in the Wake of a Fraud Crackdown • GSA Issues RFI to Explore Ideas to Promote Domestic Procurement on GSA Advantage
Arrest of Harvard Professor Reinforces Heightened Scrutiny of Federal Grant Recipients with Connections to China
J Dennis | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.